findmyKOL

Daniel Haggstrom, MD

Basic profile

Carolinas Medical Center

ORCIDNone on fileNPI
RegionCharlotte, NC · SoutheastSpecialtyMedical OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Daniel Haggstrom is an Oncology physician affiliated with Carolinas Medical Center. OpenAlex indexes 49 publications with 3,134 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
49publications

Distinct works indexed by OpenAlex.

3,134citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4525 Cameron Valley Pkwy
Ste 3500
Charlotte, NC 282114369

Telephone

704-302-8300

Registry record last updated 25 Sept 2025.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    27.7%
    Other antiepileptics9.9%
    Levetiracetam100%
    Part D17 patients
    Central Nervous System Stimulant6.5%
    Methylphenidate Hcl100%
    Part D15 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    18.6%
    Serotonin-3 Receptor Antagonist10%
    Ondansetron Hcl100%
    Part D42 patients
    Proton pump inhibitor4.9%
    Omeprazole60%Pantoprazole Sodium40%
    Part D<11 patients

    + 1 more class in this area

  • Cancer & immunology

    15.6%
    Kinase inhibitor6.9%
    Tagrisso51%Calquence49%
    Part D<11 patients
    Other antineoplastic agents3.4%
    Krazati54%Lumakras46%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)57.8% facility · 42.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”